Concord Wealth Partners Pacific Biosciences Of California, Inc. Transaction History

Concord Wealth Partners

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 27, 2023	BUY	$5.67 - $11.2 $130 - $257	23 New	23 $0
Q2 2022 Aug 04, 2022	SELL	$4.02 - $10.43 $6,335 - $16,437	-1,576 Reduced 94.43%	93 $0
Q1 2022 Apr 20, 2022	SELL	$8.43 - $20.9 $13,985 - $34,673	-1,659 Reduced 49.85%	1,669 $15,000
Q4 2021 Jan 21, 2022	BUY	$19.26 - $30.08 $44,201 - $69,033	2,295 Added 222.17%	3,328 $68,000
Q3 2021 Nov 09, 2021	SELL	$24.86 - $35.02 $40,173 - $56,592	-1,616 Reduced 61.0%	1,033 $26,000
Q2 2021 Jul 29, 2021	SELL	$22.3 - $36.02 $11,038 - $17,829	-495 Reduced 15.74%	2,649 $93,000
Q1 2021 May 13, 2021	BUY	$26.38 - $51.15 $80,406 - $155,905	3,048 Added 3175.0%	3,144 $105,000
Q4 2020 Feb 16, 2021	BUY	$10.5 - $28.5 $1,008 - $2,736	96 New	96 $2,000

255

228M

745K

1.23M

Ticker PACB
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 224,840,992
Market Cap $450M
Description
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...

Get notified when there are updates to the investment portfolio of Concord Wealth Partners, based on Form 13F filings with the SEC.

Stay updated on Concord Wealth Partners with notifications on news.